安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Reinventing the patient experience. | Halozyme
The patient is at the forefront of everything we do at Halozyme With our disruptive drug delivery technologies and robust commercial portfolio, we are committed to reinventing the patient experience by easing the burden of treatment and improving patient outcomes
- Halozyme - Wikipedia
Halozyme licenses its Enhanze drug delivery platform technology to other biopharmaceutical companies to enable intravenous to subcutaneous administration conversion and dose optimization
- Halozyme Therapeutics, Inc. (HALO) - Yahoo Finance
Find the latest Halozyme Therapeutics, Inc (HALO) stock quote, history, news and other vital information to help you with your stock trading and investing
- Vertex taps Halozyme in $15 upfront biologics drug delivery deal
Halozyme paid $750 million in cash to acquire its subcutaneous drug delivery peer Elektrofi last fall Now, Vertex will pay $15 million upfront to leverage Hypercon for use in up to three drug
- HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1. 4 BILLION AND . . .
Halozyme is headquartered in San Diego, CA, with offices in Ewing, NJ; Minnetonka, MN; and Boston, MA Minnetonka is also the site of its operations facility
- Halozyme: How This Small Biotech Is Getting Under Your Skin | Investor . . .
Small biotech company Halozyme (HALO) has stood behind some of the biggest names in medicine, including Johnson Johnson (JNJ), Bristol Myers Squibb (BMY) and Roche (RHHBY)
- Halozyme and Vertex sign deal for Hypercon technology
Halozyme Hypercon has signed a global exclusive partnership and licence agreement with Vertex Pharmaceuticals for Hypercon technology
- Halozyme Therapeutics (HALO) Company Profile Description
Halozyme Therapeutics, Inc , a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally
|
|
|